Hubei Biocause Pharmaceutical Co (000627.SZ) Stock Price

Hubei Biocause Pharmaceutical Co., Ltd. generates revenue through its insurance business, offering life insurance, health insurance, and casualty insurance products. The company also sells pharmaceutical products like polypropylene and Ibuprofen, distributing them domestically across Central China and South China, as well as exporting to overseas markets. Its primary customers are individuals and businesses seeking insurance coverage and pharmaceutical solutions in these regions. The firm's insurance operations target customers requiring life, health, and casualty coverage, while its pharmaceutical segment serves markets where polypropylene and Ibuprofen are in demand. The company leverages its domestic presence in Central China and South China to support both insurance and pharmaceutical sales, with overseas markets expanding its reach. Revenue streams are derived from insurance premiums and product sales of polypropylene and Ibuprofen, serving both local and international clients.